3. |
Wolff K: Histologische Beobachtungen an der normalen menschlichen Haut bei der Durchführung fermenthistochemischer Untersuchungen mit Adenosintriphosphat als Substrat. Arch Klin Exp Derm 216:1-17, 1963. IF 1.421 |
12. |
Lessard R, Wolff K, Winkelmann RK: Induced "shedding" of the epidermal Langerhans cells. Nature 212:628, 1966. IF 29.491 |
21. |
Wolff K: The fine structure of the Langerhans cell granule. J Cell Biol 35:466-473, 1967. IF 12.880 |
26. |
Wolff K, Winkelmann RK: Ultrastructural localization of nucleoside triphosphatase in Langerhans cells. J Invest Dermatol 48:50-54, 1967. IF 4.903 |
32. |
Wolff K, Winkelmann RK: Quantitative studies in the Langerhans cell population of guinea pig epidermis. J Invest Dermatol 48:504-513, 1967. IF 4.903 |
15. R |
Wolff K: The Langerhans cell, in J.W.H.Mali (ed): Current Problems in Dermatology, S.Karger, Basel, New York, pp 79-145, 1972 |
39. |
Wolff K, Schreiner E: Immunosuppressive Therapie bei Pemphigus vulgaris. Vorläufige Erfahrungen mit Azathioprin (IMUREL). Arch Klin Exp Derm 235:63-77, 1969. IF 1.421 |
43. |
Wolff K, Schreiner E: An electron microscopic study on the extraneous coat of keratinocytes and the intercellular space of the epidermis. J Invest Dermatol 51:418-430, 1969. IF 4.903 |
46. |
Schreiner E, Wolff K: Systemic lupus erythematosus. Electronmicroscopic localization of in vivo bound immunoglobulins at the dermal-epidermal junction. J Invest Dermatol 55:325-328, 1970. IF 4.903 |
52. |
Wolff K, Schreiner E: Epidermal lysosomes. Electron microscopic and electron microscopic-cytochemical studies. Arch Dermatol 101:276-286, 1970. IF 2.889 |
53. |
Wolff K, Schreiner E: Uptake, intracellular transport and degradation of exogeneous protein by Langerhans cells. An electron microscopic cytochemical study using peroxidase as tracer substance. J Invest Dermatol 54:37-47, 1970. IF 4.903 |
56. |
Wolff K, Hönigsmann H: Permeability of the epidermis and phagocytic activity of keratinocytes. Ultrastructural studies with thorotrast as marker. J Ultrastr Res 36:176-190, 1971. IF 4.903 |
21. R |
Wolff K, Wolff-Schreiner EC: Trends in electron microscopy of the skin. J Invest Dermatol 67:39-57, 1976. IF 4.903 |
57. |
Wolff K, Konrad K: Melanin pigmentation: An in vivo model for studies on melanosome kinetics within keratinocytes. Science 174:1034-1035, 1971. IF 24.595 |
59. |
Wolff K, Schreiner E: Pemphigus autoantibodies: Ultrastructural localization within the epidermis. Nature 229: 59-61, 1971. IF 29.491 |
60. |
Wolff K, Hönigsmann H: Are melanosome complexes lysosomes? J Invest Dermatol 59:170-176, 1972. IF 4.903 |
61. |
Wolff K, Konrad K: Phagocytosis of latex beads by epidermal keratinocytes in vivo. J Ultrastr Res 39:262-280, 1972. IF 4.903 |
67. |
Konrad K, Wolff K: Hyperpigmentation, melanosome size, and distribution patterns of melanosomes. Arch Dermatol 107:853-860, 1973. IF 2.889 |
72. |
Elias P, Mittermayer H, Tappeiner G, Fritsch P, Wolff K: Staphylococcal toxic epidermal necrolysis (TEN). The expanded mouse model. J Invest Dermatol 63:467-475, 1974. IF 4.903 |
73. |
Elias P, Fritsch P, Tappeiner G, Mittermayer H, Wolff K: Experimental staphylococcal toxic epidermal necrolysis (TEN) in adult humans and mice. J Lab Clin Med 84:414-424, 1974. IF 1.989 |
77. |
Wolff K, Jimbow J, Fitzpatrick TB: Experimental pigment donation in vivo. J Ultrastr Res 47:400-419, 1974. IF 4.903 |
80. |
Wolff K, Hönigsmann H, Gschnait F, Konrad K: Photochemotherapie bei Psoriasis. Klinische Erfahrungen bei 152 Patienten. Dtsch Med Wschr 100:2471-2477, 1975. IF 0.684 |
84. |
Holubar K, Wolff K, Konrad K, Beutner EH: Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. Employment of a new peroxidase-antiperoxidase multistep method. J Invest Dermatol 64:220-227, 1975. IF 4.903 |
85. |
Gschnait F, Konrad K, Hönigsmann H, Denk K, Wolff K: Mouse model for erythropoietic protoporphyria. I. The liver and hepatic protoporphyrin crystals. J Invest Dermatol 65:290-299, 1975. IF 4.903 |
86. |
Konrad K, Hönigsmann H, Gschnait F, Wolff K: Mouse model for erythropoietic protoporphyria. II. Cellular and subcellular events in the photosensitivity flare of the skin. J Invest Dermatol 65:300-310, 1975. IF 4.903 |
87. |
Wolff K, Wolff-Schreiner E, Gschnait F: Liver inclusions in erythropoietic protoporphyria. Eur J Clin Res 5:21-26, 1975. |
92. |
Stingl G, Hönigsmann H, Holubar K, Wolff K: Ultrastructural localization of immunoglobulins in skin of patients with dermatitis herpetiformis. J Invest Dermatol 67:507-512, 1976. IF 4.903 |
93. |
Hönigsmann H, Gschnait F, Konrad K, Stingl G, Wolff K: Mouse model for protoporphyria. III. Experimental production of chronic erythropoietic protoporphyria-like skin lesions. J Invest Dermatol 66:188-195, 1976. IF 4.903 |
94. |
Wolff K, Fitzpatrick TB, Parrish JA, Gschnait F, Gilchrest B, Hönigsmann H, Pathak A, Tanenbaum L: Photochemotherapy for psoriasis with orally administered methoxsalen. Arch Dermatol 112: 943-950, 1976. If 2.889 |
97. |
Hönigsmann H, Stingl G, Holubar K, Wolff K: Herpes gestationis: fine structural pattern of immunoglobulin deposits in the skin in vivo. J Invest Dermatol 66:389-392, 1976. IF 4.903 |
102. |
Wolff K, Gschnait F, Hönigsmann H, Konrad K, Parrish JA, Fitzpatrick TB: Phototesting and dosimetry for photochemotherapy. Brit J Dermatol 96:1-10, 1977. IF 2.230 |
105. |
Stingl G, Wolff-Schreiner EC, Pichler WJ, Gschnait F, Knapp W, Wolff K: Epidermal Langerhans cells bear Fc and C3 receptors. Nature 268:245-246, 1977. IF 29.491 |
109. |
Fritsch P, Hönigsmann H, Jaschke E, Wolff K: Augmentation of oral methoxsalen-photochemotherapy with an oral retinoic acid derivative. J Invest Dermatol 70:178-182, 1978. IF 4.903 |
127. |
Hintner H, Stingl G, Schuler G, Fritsch P, Stanley J, Katz S, Wolff K: Immunofluorescence mapping of antigenic determinants within the dermoepidermal junction in mechanobullous diseases. J Invest Dermatol 76:113-118, 1981. IF 4.903 |
128. |
Henseler T, Wolff K, Hönigsmann H, Christophers E: The European PUVA Study (EPS): Oral 8-methoxypsoralen photochemotherapy of psoriasis. A cooperative study among 18 European centres. The Lancet I:853-857, 1981. IF 10.197 |
130. |
Aberer W, Schuler G, Stingl G, Hönigsmann H, Wolff K: Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 76:202-210, 1981. IF 4.903 |
75. R |
Wolff K, Stingl G: The Langerhans cell. J Invest Dermatol 80 (Suppl.):17s-21s, 1983. IF 4.903 |
97. R |
Stingl G, Romani N, Wolff K: Langerhans cells: a distinctive member of bone marrow-derived dendritic cells. Advanc Dermatol 2:269-282, 1987. |
133. |
Stingl G, Gazze-Stingl LA, Aberer W, Wolff K: Antigen presentation by murine epidermal Langerhans cells and its alteration by ultraviolet B light. J Immunol 127:1707-1713, 1981. IF 7.145 |
136. |
Schuler G, Hintner H, Wolff K, Fritsch P, Stingl G: In vitro complement-binding on cytoplasmic structures in normal human skin. Immunoelectron-microscopic studies. J Cell Biol 95:543-551, 1982. IF 12.880 |
139. |
Hintner H, Wolff K: Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 118:375-384, 1982. IF 2.889 |
145. |
Hönigsmann H, Wolff K: Isotretinoin-PUVA for psoriasis. Lancet I:236, 1983. IF 10.197 |
148. |
Schuler G, Stingl G, Aberer W, Gazze-Stingl LA, Hönigsmann H, Wolff K: Histiocytosis X cells in eosinophilic granuloma express Ia and T6 antigens. J Invest Dermatol 80:405-409, 1983. IF 4.903 |
154. |
Volc-Platzer B, Majdic O, Knapp W, Wolff K, Hinterberger W, Lechner K, Stingl G: Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med 159:1784-1789, 1984. IF 15.651 |
155. |
Volc-Platzer B, Stingl G, Wolff K, Hinterberger W, Schnedl W: Cytogenetic identification of allogeneic epidermal Langerhans cells in a bone-marrow graft recipient. N Engl J Med 310:1123-1124, 1984. IF 28.857 |
162. |
Rappersberger K, Konrad K, Wieser E, Weber H, Wolff K: Morphological changes in peripheral blood cells and skin in amiodarone-treated patients. Brit J Dermatol 114:189-196, 1986. IF 2.230 |
168. |
Wolff K, Rappersberger K, Steiner A, Konrad K: Vegetating cicatricial pemphigoid. A new subset of the cicatricial pemphigoid spectrum. Arch Dermatol Res 279:30-37, 1987. IF 1.421 |
169. |
Steiner A, Pehamberger H, Wolff K: In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma. J Amer Acad Dermatol 17:584-591, 1987. IF 1.905 |
170. |
Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig G, McKiernan G, Christiansen I, Oster M, Hönigsmann H, Wilfert H, Kokoschka EM, Rehle T, Perez M, Stingl G, Laroche L: Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 316:297-303, 1987. IF 28.852 |
175. |
Tschachler E, Groh V, Popovic M, Mann DL, Konrad K, Safai B, Eron L, diMarzo Veronese F, Wolff K, Stingl G: Epidermal Langerhans cells - a target for HTLV-III/LAV infection. J Invest Dermatol 88:233-237, 1987. IF 4.903 |
176. |
Henseler T, Christophers E, Hönigsmann H, Wolff K: The European PUVA study - follow-up. I. Skin tumors following oral methoxsalen photochemotherapy. An eight year follow-up study of 1643 patients treated with PUVA for psoriasis. J Amer Acad Dermatol 16:108-116, 1987. IF 1.905 |
178. |
Pehamberger H, Steiner A, Wolff K: In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Amer Acad Dermatol 17:571-583, 1987. IF 1.905 |
186. |
Rappersberger K, Gartner S, Schenk P, Stingl G, Groh V, Tschachler E, Mann DL, Wolff K, Konrad K, Popovic M: Langerhans cells are an actual site of HTLV-III/LAV replication. Intervirol 29:185-194, 1988. |
187. |
Groh V, Gadner H, Radaszkiewicz T, Rappersberger K, Konrad K, Wolff K, Stingl G: The phenotype spectrum of histiocytosis X cells. J Invest Dermatol 90:441-447, 1988. IF 4.903 |
196. |
Rappersberger K, Tschachler E, Zonzits E, Gillitzer R, Hatzakis A, Kaloterakis A, Mann DL, Popow-Kraupp T, Biggar RJ, Berger R, Stratigos J, Wolff K, Stingl G: Endemic Kaposi′s sarcoma in human immunodeficiency virus type 1- seronegative persons: Demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol 95:371-381, 1990. IF 4.903 |
200. |
Volc-Platzer B, Hönigsmann H, Hinterberger W, Wolff K: Photochemotherapy improves chronic cutaneous graft-versus-host disease. J Amer Acad Dermatol 23:220-228, 1990. IF 1.905 |
213. |
Binder M, Dolezal I, Wolff K, Pehamberger H: Stereologic estimation of volume weighted mean nuclear volume as a predictor of prognosis in thin malignant melanoma. J Invest Dermatol 99:180-183, 1992. IF 4.903 |
220. |
Petzelbauer P, Födinger D, Rappersberger K, Volc-Platzer B, Wolff K: CD68-positive epidermal dendritic cells. J Invest Dermatol 101:256-261, 1993. IF 4.903 |
227. |
Binder M, Steiner A, Mossbacher U, Knollmayer S, Wolff K, Pehamberger H: Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. Brit J Dermatol 130:460-465, 1994. IF 2.230 |
230. |
Födinger D, Anhalt GJ, Böcskör B, Elbe A, Wolff K, Rappersberger K: Autoantibodies to desmoplakin I and II in patients with erythema multiforme. J Exp Med 181:169-179, 1995. IF 15.651 |
231. |
Stingl G, Wolff K, Bröcker EB, Mertelsmann R, Schneeberger A, Schreiber S, Dummer W, Kämpgen E, Brennscheid U, Veelken H, Birnstiel M, Maass G, Zatloukal K, Buschle M, Wagner E, Kempe ER, Weber HA, Voigt T: Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Gene Therapy 7:551-563, 1995. IF 5.237 |
242. |
Rappersberger K, Meingassner J, Fialla R, Födinger D, Sterniczky B, Rauch S, Putz E, Stütz A, Wolff K: Clearing of psoriasis by a novel immunosuppressive macrolide. J Invest Dermatol 106:701-710, 1996. IF 4.903 |
244. |
Gröger M, Sarmay G, Fiebiger E, Wolff K, Petzelbauer P: Dermal microvascular endothelial cells express CD32 receptors (FcτRIIa) in vivo and in vitro. J Immunol 156:1549-1556, 1996. IF 7.145 |
245. |
Jansen B, Schlagbauer-Wadl H, Eichler HG, Wolff K, van Elsas A, Schrier PI, Pehamberger H: Activated N-ras contributes to the chemoresistance of human melanoma in SCID mice. Cancer Res 57:362-365, 1997. IF 8.614 |
253. |
Matsumura T, Wolff K, Petzelbauer P: Endothelial cell tube formation depends on both, cadherin 5 and CD31 interactions with filamentous actin. J Immunol 58:3408-3416, 1997. IF 7.145 |
254. |
Wolff K: Should PUVA be abandoned? (Editorial) N Engl J Med 336:1090-1091, 1997. IF 28.857 |
261. |
Pehamberger H, Soyer P, Steiner A, Kofler R, Binder M, Mischer P, Pachinger W, Auböck J, Fritsch P, Kerl H, Wolff K: Adjuvant interferon alpha-2a treatment in resected primary cutaneous melanoma. J Clin Oncol 16:1425-1429, 1998. IF 7.963 |
265. |
Binder M, Kittler H, Seeber A, Steiner A, Pehamberger H, Wolff K: Epiluminescence microscopy-based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Mel Res 8:261-266, 1998. |
266. |
Jansen B, Schlagbauer-Wadl H, Drown B, Bryan R, van Elsas A, Müller M, Wolff K, Eichler HG, Pehamberger H: BCL-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nature Medicine 4:232-234, 1998. IF 26.584 |
270. |
Jansen B, Heere-Ress E, Schlagbauer-Wadl H, Halaschek-Wiener J, Waltering S, Moll I, Pehamberger H, Marciano D, Kloog Y, Wolff K: Farnesylthiosalicylic acid (FTS) inhibits the growth of human merkel cell carcinoma in SCID mice. J Molec Med 77:792-797, 1999. IF 3.721 |
272. |
Gröger M, Fischer G, Wolff K, Petzelbauer P: Immune complexes from vasculitis patients bind to endothelial Fc receptors independent of the allelic polymorphism of FcRIIa. J Invest Dermatol 113:56-60, 1999. IF 4.903 |
275. |
Schreiber S, Kämpgen E, Wagner E, Pirkhammer D, Trcka J, Korschan H, Lindemann A, Dorffner R, Kasteliz F, Küpcü Z, Sinski A, Zatloukal K, Buschle M, Schmidt W, Birnstiel M, Kempe R, Voigt T, Weber H, Mertelsmann R, Bröcker E, Wolff K, Stingl G: Immunotherapy of metastatic malignant melanoma by a vaccine. Consisting of autologous IL-2-transfected cancer cells - outcome of a Phase I study. Proc Natl Acad Sci 10:983-993, 1999. IF 10.789 |
276. |
Jansen B, Schlagbauer-Wadl H, Kahr H, Heere-Ress E, Mayer B, Eichler H-G, Pehamberger H, Ganza-Weisz M, Ben-David E, Kloog Y, Wolff K: Novel ras antagonists blocks human melanoma growth. Proc Natl Acad Sci 96:14019-14024, 1999. IF 10.789. |
286. |
Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nunez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RZ, Austen KF, Lennert K, Metcalf DD, Vardiman JW, Bennett JM: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leukemia Research 25:603-625, 2001. IF 1.142 |
289. |
Bergmann M, Romirer I, Sachet M, Fleischhacker R, Garcia-Sastre A, Palese P, Wolff K, Pehamberger H, Jakesz R, Muster T: A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res 61:8188-8193, 2001. IF 9.614 |
290. |
Halama T, Gröger M, Pillinger M, Staffler G, Prager E, Stockinger H, Holnthoner W, Lechleitner S, Wolff K, Petzelbauer P: Platelet endothelial cell adhesion molecule-1 and vascular endothelial cadherin cooperatively regulate fibroblast growth factor-induced modulations of adherens junction functions. J Invest Dermatol 116:110-117, 2001. IF 4.903 |
298. |
Holnthoner W, Pillinger M, Groger M, Wolff K, Ashton A, Albanese C, Neumeister P, Pestell R, Petzelbauer P: Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. J Biol Chem 277:45847-45853, 2002. IF 7.258 |
304. |
Rappersberger K, Komar M, Ebelin ME, Scott G, Burtin P, Greig G, Kehren J, Chibout SD, Cordier A, Holter W, Richter L, Oberbauer R, Stütz A, Wolff K: Pimecrolimus identifies a common genomic antiinflammatory profile, is clinically highly effective in psoriasis and is well tolerated. J Invest Dermatol 119:876-887, 2002. IF 4.903 |
306. |
Kittler H, Pehamberger H, Wolff K, Binder M: Diagnostic accuracy of dermoscopy. The Lancet Oncology 3:159-165, 2002. |
308. |
Kunstfeld R, Wickenhauser G, Michaelis U, Teifel M, Umek W, Naujoks K, Wolff K, Petzelbauer P: Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model. J Invest Dermatol 120:476-482, 2003. IF 4.645 |
309. |
Ortiz-Urda S, Elbe-Bürger A, Smolle J, Marquardt Y, Chudnovsky Y, Ridky T, Bernstein P, Wolff K, Rappersberger K: The plant lectin wheat germ agglutinin inhibits the binding of pemphigus foliaceus autoantibodies to desmoglein 1, and prevents pathomechanisms of pemphigus foliaceus in vitro and in vivo. J Immunol 171:6244-6250, 2003. |
316. |
Muster T, Waltenberger A, Grassauer A, Hirschl S, Caucig P, Romirer I, Foedinger D, Seppele H, Magin-Lachmann C, Löwer R, Jansen B, Pehamberger H, Wolff K: An endogenous retrovirus derived from human melanoma cells. Cancer Res 63:8735-8741, 2003. IF 9.614 |
323 |
Petzelbauer P, Zacharowski PA, Miyazaki Y, Friedl P, Wickenhauser G, Castellino FJ, Gröger M, Wolff K, Zacharowski K: The fibrin-derived peptide Bβ15-42 protects the myocardium against ischemia-reperfusion injury. Nature Medicine 11:298-304, March 2005. IF 26.584 |